These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 38293886)

  • 1. Unraveling the complexities of IgG4-related disease: Musings from a histopathologist.
    Deshpande V
    Semin Diagn Pathol; 2024 Mar; 41(2):43-44. PubMed ID: 38238220
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the editor regarding Immunoglobulin G4-related disease in a dog.
    Watson P; Coddou F; Blacklaws B; Bazelle J; Day M; Constantino-Casas F
    J Vet Intern Med; 2020 Mar; 34(2):542-543. PubMed ID: 32104928
    [No Abstract]   [Full Text] [Related]  

  • 3. IgG4-Related Disease, A Single-Center Experience.
    Fernández-Codina A; Haig S; Pope JE; Barra L
    J Clin Rheumatol; 2021 Dec; 27(8S):S590-S591. PubMed ID: 30585995
    [No Abstract]   [Full Text] [Related]  

  • 4. IgG4-Related Disease: A Diagnosis After 15 Years.
    Zloto O; Rose GE; Marjanovic B
    Ophthalmic Plast Reconstr Surg; 2022 Jul-Aug 01; 38(4):e129. PubMed ID: 35353781
    [No Abstract]   [Full Text] [Related]  

  • 5. Left Ventricular Dysfunction Caused by IgG4-related Small Intramural Coronary Periarteritis.
    Hada T; Amano M; Irie Y; Moriuchi K; Okada A; Matsumoto M; Takahama H; Amaki M; Kanzaki H; Ikeda Y; Hatakeyama K; Kusano K; Noguchi T; Izumi C
    Intern Med; 2022 Jan; 61(1):59-63. PubMed ID: 34219111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing IgG4-related disease - the Portuguese rheumatology cohort.
    Parente H; Carones A; Silva A; Silva B; Costa C; Soares CD; Santos I; Bernardes JM; Silvério-António M; Torres RP; Teixeira F
    ARP Rheumatol; 2024; 3(1):70-72. PubMed ID: 38558068
    [No Abstract]   [Full Text] [Related]  

  • 7. IgG4-Related Pancreato-Biliary Disease in the Disguise of Malignancy.
    Mathew A; Rakesh NR; Kaushal G; Ramachandra D; Goyal A; Karthyarth MN; Azad S; Sanyal S; Dhar P
    Am Surg; 2023 Jun; 89(6):2985-2988. PubMed ID: 35576564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [IgG4-Related Disease from the Pancreatologist's point of view].
    Berger Z; Asencio CM
    Rev Med Chil; 2023 Mar; 151(3):392-393. PubMed ID: 38293886
    [No Abstract]   [Full Text] [Related]  

  • 9. IgG4-related disease. Clinical manifestation differential diagnosis and recent International Diagnostic Criteria for IgG4-related disease.
    Adam Z; Zeman D; Čermák A; Dastych M; Doubková M; Horváth T; Skorkovská Š; Adamová Z; Řehák Z; Koukalová R; Pour L; Štork M; Krejčí M; Sandecká V; Ševčíková S; Král Z
    Vnitr Lek; 2022; 68(E-5):4-19. PubMed ID: 36283812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG4-related Lung Disease: A Case Report and Review of the Literature.
    Zheng X; Zou W; Zou S; Ye J; Bao Z; Hong J; Song Y
    Altern Ther Health Med; 2023 Nov; 29(8):320-323. PubMed ID: 37632955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Immunoglobulin G4-Related Ophthalmic Disease and Nonlymphoid Malignancy Case Series and Comprehensive Review of the Literature.
    Hou Y; Su Q; Li J; Zhou H; Li H
    J Neuroophthalmol; 2023 Mar; 43(1):102-109. PubMed ID: 35921572
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.